Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$40.7K Sell
624
-999
-62% -$73.1K ﹤0.01% 1412
2025
Q4
$131K Sell
1,623
-86
-5% -$6.91K ﹤0.01% 941
2025
Q3
$140K Sell
1,709
-190
-10% -$16.5K ﹤0.01% 939
2025
Q2
$173K Buy
1,899
+313
+20% +$28K ﹤0.01% 819
2025
Q1
$145K Buy
1,586
+478
+43% +$41.7K ﹤0.01% 837
2024
Q4
$94.3K Sell
1,108
-692
-38% -$60.7K ﹤0.01% 962
2024
Q3
$142K Buy
1,800
+662
+58% +$55.7K ﹤0.01% 1033
2024
Q2
$103K Buy
1,138
+174
+18% +$14.3K ﹤0.01% 960
2024
Q1
$87.1K Sell
964
-454
-32% -$41.4K ﹤0.01% 747
2023
Q4
$119K Buy
1,418
+215
+18% +$17.9K ﹤0.01% 613
2023
Q3
$119K Buy
1,203
+543
+82% +$49K ﹤0.01% 575
2023
Q2
$63K Sell
660
-2,481
-79% -$233K ﹤0.01% 626
2023
Q1
$285K Buy
3,141
+1,199
+62% +$111K ﹤0.01% 423
2022
Q4
$154K Buy
1,942
+1,097
+130% +$93.3K ﹤0.01% 542
2022
Q3
$70K Buy
845
+612
+263% +$51.8K ﹤0.01% 643
2022
Q2
$19K Buy
+233
New +$19.2K ﹤0.01% 966

Other funds holding DOX

Blue Trust Inc's DOX Position: Q1 2026 in Review

Blue Trust Inc reduced its Amdocs (DOX) stake by 62% in Q1 2026, selling an estimated $73.1K and leaving 624 shares worth $40.7K. The position accounts for ﹤0.01% of the portfolio, ranked #1412.

Blue Trust Inc first reported a position in DOX in Q2 2022 and has held it in 16 quarters since. The position peaked at $285K in Q1 2023. 473 funds tracked by Wall St. Rank hold DOX as of Q1 2026.

  • Blue Trust Inc held 624 shares of Amdocs worth $40.7K as of Q1 2026.
  • Blue Trust Inc sold 999 Amdocs shares in Q1 2026, an estimated $73.1K.
  • Amdocs made up ﹤0.01% of Blue Trust Inc's portfolio in Q1 2026, its #1412 holding.
  • Blue Trust Inc first reported a position in Amdocs in Q2 2022 and has held it in 16 quarters since.
  • Blue Trust Inc's Amdocs position peaked at $285K in Q1 2023.
  • 473 funds tracked by Wall St. Rank held Amdocs as of Q1 2026.

Based on Blue Trust Inc's 13F filing for Q1 2026, filed 20 Apr 2026.